Squarepoint Ops LLC Ascendis Pharma A/S Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$86.1 - $127.36 $451,508 - $667,875	-5,244 Reduced 47.14%	5,881 $740,000
Q2 2023 Aug 14, 2023	BUY	$69.96 - $97.84 $778,304 - $1.09 Million	11,125 New	11,125 $992,000
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $1.14 Million - $1.5 Million	13,609 Added 365.83%	17,329 $1.79 Million
Q2 2022 Aug 15, 2022	BUY	$78.08 - $117.61 $290,457 - $437,509	3,720 New	3,720 $346,000
Q1 2022 May 16, 2022	SELL	$102.18 - $135.75 $186,580 - $247,879	-1,826 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$127.1 - $169.66 $264,622 - $353,232	-2,082 Reduced 53.28%	1,826 $246,000
Q3 2021 Nov 15, 2021	SELL	$112.67 - $176.92 $289,449 - $454,507	-2,569 Reduced 39.66%	3,908 $623,000
Q2 2021 Aug 16, 2021	BUY	$121.62 - $145.29 $787,732 - $941,043	6,477 New	6,477 $852,000
Q4 2020 Feb 16, 2021	SELL	$151.2 - $182.76 $478,699 - $578,618	-3,166 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$134.29 - $154.32 $425,162 - $488,577	3,166 New	3,166 $489,000
Q2 2020 Aug 14, 2020	SELL	$110.87 - $156.01 $379,175 - $533,554	-3,420 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$97.01 - $145.11 $331,774 - $496,276	3,420 New	3,420 $385,000
Q2 2019 Aug 14, 2019	SELL	$107.11 - $132.09 $790,364 - $974,692	-7,379 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$62.15 - $129.99 $255,995 - $535,428	4,119 Added 126.35%	7,379 $869,000
Q4 2018 Feb 14, 2019	BUY	$55.16 - $69.67 $179,821 - $227,124	3,260 New	3,260 $204,000
Q3 2018 Nov 14, 2018	SELL	$63.77 - $76.28 $274,211 - $328,004	-4,300 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$58.55 - $73.92 $70,260 - $88,704	-1,200 Reduced 21.82%	4,300 $286,000
Q1 2018 May 15, 2018	BUY	$38.98 - $68.04 $214,389 - $374,220	5,500 New	5,500 $360,000

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

Ra Capital Management, L.P. Boston, MA

9.71M
Shares

$1.32 Billion
20.22% of portfolio
Westfield Capital Management CO LP Boston, MA

5.13M
Shares

$700 Million
3.62% of portfolio
Avoro Capital Advisors LLC New York, NY

4.99M
Shares

$680 Million
11.21% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

4.41M
Shares

$602 Million
1.03% of portfolio
Janus Henderson Group PLC London, X0

4.19M
Shares

$571 Million
0.33% of portfolio

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account